Background: The study was conducted to evaluate the diagnostic performance of magnetic resonance imaging (MRI) for the detection of axillary lymph node metastasis in patients with breast cancer. Methods: PubMed, Medline, Web of Science, Cochrane Embase, Chinese Biomedical Literature, and China National Knowledge Infrastructure databases were searched for open published studies relevant to the use of MRI for the detection of axillary lymph node metastasis in breast cancer patients. The pooled diagnostic sensitivity, specificity, and the symmetric receiver operating characteristic (SROC) curve was calculated by combining the individual data extracted from 26 included studies. Results: The pooled diagnostic sensitivity and specificity of MRI to detect axillary lymph node metastasis in patients with breast cancer were 0.77 (95% confidence interval [CI] 0.75-0.80) and 0.90 (95% CI 0.89-0.91), respectively. The pooled positive and negative likelihood ratios were 7.67 (95% CI 5.09-11.53) and 0.23 (95% CI 0.17-0.32), respectively, by random effect method. The area under the SROC curve was 0.93 for MRI to detect axillary lymph node metastasis in breast cancer patients. Conclusion: With high sensitivity, specificity, and area under the curve, MRI is an effective method to differentiate metastatic axillary lymph node in breast cancer patients, which can provide useful information for surgical procedure selection.
Introduction
Statistical studies of cancer have revealed that breast cancer is one of the most common malignant carcinomas diagnosed and the seconding leading cause of cancer relateddeath in women. [1] [2] [3] Axillary lymph node metastasis is common in breast cancer patients, which also affects the treatment modality and surgical procedure. 4 Axillary lymph node status of patients with breast cancer is usually assessed by sentinel lymph node biopsy (SLNB), core needle biopsy (CNB), or fine needle aspiration cytology (FNAC). However, these procedures are mini-invasive and potentially lead to implantation metastasis. Magnetic resonance imaging (MRI), with high resolution of different tissues, is widely used to diagnose many types of cancers and also affects treatment modality. Previously studies have evaluated its performance for evaluating the axillary lymph node status of patients with breast cancer. However, because of the small sample sizes of previous studies, statistical research is limited. In our present study, we searched open published studies relevant to MRI for the detection of axillary lymph node metastasis in patients with breast cancer and conducted a meta-analysis to further evaluate diagnostic performance.
Infrastructure databases were searched for open published studies relevant to the use of MRI to detect axillary lymph node metastasis in patients with breast cancer. The search procedure is demonstrated in Figure 1 . The terms "breast cancer" OR "breast carcinoma" OR "breast neoplasm" And "axillary lymph node" And "MRI" OR "magnetic resonance imaging" OR "MR" were used.
Study inclusion and exclusion
Two reviewers drew up the inclusion and exclusion criteria and crosschecked the data. The inclusion criteria were: (i) prospective or retrospective diagnostic studies; (ii) studies relevant to the evaluation of MRI to detect axillary lymph node metastasis in patients with breast cancer; (iii) the axillary lymph node metastasis was confirmed by pathological examination; and (iv) the number of true positive (TP), false positive (FP), false negative (FN), and true negative (TN) results could be extracted from each individual study. The exclusion criteria were: (i) duplicate publications or data; (ii) literature review of case reports; (iii) malignant carcinoma other than breast cancer; and (iv) diagnostic data could not be extracted from individual studies.
Initially, 268 relevant studies were identified. Nineteen duplicated publications or data were excluded. After reading the title and abstract, 204 studies were excluded. After review of the full text, a further 19 studies were excluded. Twenty-six open published studies were finally included in the meta-analysis (Fig 1) . The main features of the included 26 studies are listed in Table 1 .
Data extraction
Two reviewers independently reviewed the data of each included study. General information, such as sample size, year of publication, diagnostic gold standard, and patient age, were extracted. The number of TP, FP, FN, and TN results were carefully extracted from each study and crosschecked.
Statistical methods
All analysis was performed using MetaDiSc 1.4 software (http://www.hrc.es/investigacion/metadisc_en.htm). Statistical heterogeneity across the 26 included studies was assessed by I 2 test. The data was pooled by fixed or random effect method according to the heterogeneity. Publication bias was assessed by line regression test. Diagnostic sensitivity and specificity was calculated using the formula: sensitivity = TP/(TP + FN) and specificity = TN/(TN + FP). P < 0.05 was considered statistically significant.
Results

Sensitivity and specificity analysis
The diagnostic sensitivity and specificity of MRI to detect axillary lymph node metastasis in patients with breast cancer were pooled by random effect method because of significant statistical heterogeneity (I 2 = 86.6% for sensitivity; I 2 = 92.5% for specificity). The pooled sensitivity and specificity were 0.77 (95% confidence interval [CI] 0.75-0.80) (Fig 2) and 0.90 (95% CI 0.89-0.91) (Fig 3) , respectively.
Positive and negative likelihood ratios
The pooled positive and negative likelihood ratios were 7.67 (95% CI 5.09-11.53) (Fig 4) and 0.23 (95% CI 0.17-0.32), respectively, by random effect method (Fig 5) .
Diagnostic odds ratio
Because of significant heterogeneity across the included 26 studies (I 2 = 80.9%; P < 0.05), the diagnostic odds ratio (DOR) was pooled by random effect method. The pooled DOR was 36.69, with a 95% confidence interval of 22.09-60.92 (Fig 6) .
Symmetric receiver operating characteristic curve
The symmetric receiver operating characteristic (SROC) curve was calculated by sensitivity against 1-specificity using MetaDiSc 1.4 software. The area under the SROC curve (AUC) was 0.93 for MRI for the detection of axillary lymph node metastasis in breast cancer patients (Fig 7) .
Evaluation of publication bias
The studies were evaluated by line regression test and no significant publication bias was observed (t = 0.33; P > 0.05) (Fig 8) . 
Specificity (95% CI)
Pooled Specificity = 0.90 (0.89-0.91) Chi-square = 346.72; df = 25 (P = 0.0000) Inconsistency (I-square) = 92.8% Figure 3 Forest plot of pooled diagnostic specificity. CI, confidence interval.
term (five-year) survival rate of breast cancer in women is approximately 90%. As described in previous studies, axillary lymph node involvement is one the key factors relevant to prognosis in breast cancer patients. A clear understanding of the status of axillary lymph nodes in breast cancer patients is important not only for prognosis but also to select treatment modality or surgical method. Axillary lymph node dissection (ALND) is the reference standard for evaluating lymph node involvement. However, approximately 40-70% of breast cancer patients have histopathologically negative axillary lymph nodes 32 indicating that 40-70% of breast cancer patients undergo unnecessary invasive examinations. Determining axillary lymph node involvement before treatment or dissection is important to reduce such examinations.
Positive LR (95% CI)
Random Effects Model
The diagnostic performance of MRI to detect axillary lymph node metastasis in patients with breast cancer has been widely discussed. However, the exact diagnostic performance of MRI for discriminating axillary lymph node involvement is not fully understood because of the inconsistent results reported by previous studies. 25, 26, 28 These inconsistencies may be the result of: (i) small sample sizes with limited statistical power; (ii) patient inclusion criteria; (iii) MRI examination technology; (iv) types of MRI instruments used; and (v) different reference standards for axillary lymph node involvement.
In our present study, we included 26 studies that evaluated the diagnostic performance of MRI to determine Figure 7 Pooled symmetric receiver operating characteristic (SROC) curves. AUC, area under the curve; SE, standard error. Figure 8 Egger's line regression test to evaluate publication bias.
axillary lymph node involvement in breast cancer and pooled the diagnostic sensitivity (0.77, 95% CI 0.75-0.80), specificity (0.90, 95% CI 0.89-0.91), and SROC (0.92) to further assess its value in clinical application. However, there are some limitations to our meta-analysis. Firstly, we only searched for studies published in English or Chinese, which may have led to publication selection bias. Secondly, significant statistical heterogeneity existed in the sensitivity, specificity, positive and negative likelihood ratios, and ROC effect sizes. Thirdly, not all of the included studies were prospective, reducing the reliability of our results. Our results show that MRI is an effective method for differentiating metastatic axillary lymph nodes in breast cancer patients because of high sensitivity, specificity, and AUC, and thus can provide useful information for surgical procedure selection.
